Discover the newest research about AI innovations in π§ͺ Drug Discovery.
AI models assess physiological age using biomarkers, impacting drug metabolism. Key predictors include glycohemoglobin and systolic blood pressure. π§¬π
AI model predicts dual-target medications, aiding in drug development for more effective treatments. π§ͺπ
Antibiotic resistance is a pressing issue. π¦ New antibiofilm strategies may offer hope for treating stubborn infections. π‘
BiomedGPT combines AI for biomedical images and text, enhancing healthcare insights and decision-making. π€π©Ί
New AI tool PIONEER predicts protein interactions, aiding drug development for over 10,500 diseases. π§¬π
AI enhances pharmaceutical safety by predicting product recalls. Key factors include formulation complexity and manufacturing processes. ππ
Cordia myxa shows promise against malaria. πΏ Key compounds identified may target IL6 and CASP3. π¦ Further studies needed.
FuseLinker enhances link prediction in biomedical knowledge graphs using advanced embeddings and GNNs. Promising results for drug repurposing! ππ
AlphaFold’s impact on molecular biology is significant. π Emerging trends and research hotspots reveal vast exploration opportunities. π
AI-driven protein analysis transforms cancer treatment, enhancing diagnosis and drug design. Promising advancements in personalized healthcare. π§¬π‘
